Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

$CD4^+CD25^{high}FoxP3^+$ Regulatory T-cells in Hematologic Diseases

  • Moon, Hee-Won (Department of Laboratory Medicine, Konkuk University School of Medicine) ;
  • Kim, Bo-Hyun (Department of Laboratory Medicine, Konkuk University School of Medicine) ;
  • Park, Chul-Min (Department of Laboratory Medicine, Konkuk University School of Medicine) ;
  • Hur, Mi-Na (Department of Laboratory Medicine, Konkuk University School of Medicine) ;
  • Yun, Yeo-Min (Department of Laboratory Medicine, Konkuk University School of Medicine) ;
  • Kim, Sung-Yong (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Lee, Mark-Hong (Department of Internal Medicine, Konkuk University School of Medicine)
  • Published : 2011.10.30
⟨ Previous Next ⟩

Abstract

Background: $CD4^+CD25^+$ regulatory T-cells (Tregs) play a critical role in immune responses. We explored the status of Tregs in neoplastic and autoimmune hematologic diseases. We also evaluated the technical aspects of Treg measurement in terms of sample type and detection markers. Methods: A total of 68 subjects were enrolled: 11 with AML, 8 with MDS, 10 with autoimmune diseases, and 39 controls. Tregs were analyzed in peripheral blood (PB) and bone marrow (BM) samples from each subject. Flow cytometry and the Human Regulatory T cell Staining Kit (eBioscience, USA) for CD4, CD25, and FoxP3 (forkhead box P3) were used. Results: The$CD4^+CD25^{high}$/CD4 and $CD4^+CD25^{high}FoxP3^+$/CD4 populations were significantly correlated (P<0.0001). The AML and high-risk MDS groups had significantly larger $CD4^+CD25^{high}$/CD4 and $CD4^+CD25^{high}FoxP3^+$/CD4 populations in PB than the autoimmune (P=0.007 and 0.012, respectively) and control groups (P=0.004 and 0.006, respectively). Comparable findings were observed in BM. The $CD4^+CD25^{high}FoxP3^+$/CD4 population was significantly larger in PB than in BM (P=0.0003). Conclusions: This study provides comparison data for Tregs in AML, MDS, and autoimmune hematologic diseases, and would be helpful for understanding the different immunologic bases of various hematologic diseases. Treg measurement using CD4, CD25, and/or FoxP3 in PB rather than in BM seems to be practical for routine hematologic purposes. Large-scale analysis of the diagnostic role of Treg measurement is needed.

Keywords

References

  1. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-87. https://doi.org/10.1016/j.cell.2008.05.009
  2. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-61. https://doi.org/10.1126/science.1079490
  3. Ozdemir C, Akdis M, Akdis CA. T regulatory cells and their counterparts: masters of immune regulation. Clin Exp Allergy 2009;39: 626-39. https://doi.org/10.1111/j.1365-2222.2009.03242.x
  4. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000;101:455-8. https://doi.org/10.1016/S0092-8674(00)80856-9
  5. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007;8:191-7. https://doi.org/10.1038/ni1428
  6. Wang HY and Wang RF. Regulatory T cells and cancer. Curr Opin Immunol 2007;19:217-23. https://doi.org/10.1016/j.coi.2007.02.004
  7. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10:942-9. https://doi.org/10.1038/nm1093
  8. Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001;61:4766-72.
  9. Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 2006;107:3639-46. https://doi.org/10.1182/blood-2005-08-3376
  10. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003;9:4404-8.
  11. Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 2005;102:18538-43. https://doi.org/10.1073/pnas.0509182102
  12. Kordasti SY, Ingram W, Hayden J, Darling D, Barber L, Afzali B, et al. CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood 2007;110:847-50. https://doi.org/10.1182/blood-2007-01-067546
  13. Motta M, Rassenti L, Shelvin BJ, Lerner S, Kipps TJ, Keating MJ, et al. Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia. Leukemia 2005;19:1788-93. https://doi.org/10.1038/sj.leu.2403907
  14. Beyer M, Kochanek M, Giese T, Endl E, Weihrauch MR, Knolle PA, et al. In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. Blood 2006; 107:3940-9. https://doi.org/10.1182/blood-2005-09-3671
  15. Nadal E, Garin M, Kaeda J, Apperley J, Lechler R, Dazzi F. Increased frequencies of CD4(+)CD25(high) T(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia 2007;21:472-9. https://doi.org/10.1038/sj.leu.2404522
  16. Wang X, Zheng J, Liu J, Yao J, He Y, Li X, et al. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients. Eur J Haematol 2005;75:468-76. https://doi.org/10.1111/j.1600-0609.2005.00537.x
  17. Swerdlow S, Campo E, et al. eds. WHO classification of tumours of hematopoietic and lymphoid tissue. Lyon: IARC Press, 2008.
  18. Kotsianidis I, Bouchliou I, Nakou E, Spanoudakis E, Margaritis D, Christophoridou AV, et al. Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS). Leukemia 2009;23:510-8. https://doi.org/10.1038/leu.2008.333
  19. Sloand EM and Rezvani K. The role of the immune system in myelodysplasia: implications for therapy. Semin Hematol 2008;45:39-48. https://doi.org/10.1053/j.seminhematol.2007.11.006
  20. Aggarwal S, van de Loosdrecht AA, Alhan C, Ossenkoppele GJ, Westers TM, Bontkes HJ. Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy. Br J Haematol 2011;153:568-81. https://doi.org/10.1111/j.1365-2141.2011.08683.x
  21. Azuma T, Takahashi T, Kunisato A, Kitamura T, Hirai H. Human CD4+ CD25+ regulatory T cells suppress NKT cell functions. Cancer Res 2003;63:4516-20.
  22. Beyer M and Schultze JL. Regulatory T cells in cancer. Blood 2006; 108:804-11. https://doi.org/10.1182/blood-2006-02-002774
  23. Feyler S, von Lilienfeld-Toal M, Jarmin S, Marles L, Rawstron A, Ashcroft AJ, et al. CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden. Br J Haematol 2009;144:686-95. https://doi.org/10.1111/j.1365-2141.2008.07530.x
  24. Solomou EE, Rezvani K, Mielke S, Malide D, Keyvanfar K, Visconte V, et al. Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood 2007;110:1603-6. https://doi.org/10.1182/blood-2007-01-066258
  25. Szczepanski MJ, Szajnik M, Czystowska M, Mandapathil M, Strauss L, Welsh A, et al. Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia. Clin Cancer Res 2009;15:3325-32. https://doi.org/10.1158/1078-0432.CCR-08-3010
  26. Yu J, Heck S, Patel V, Levan J, Yu Y, Bussel JB, et al. Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood 2008;112:1325-8. https://doi.org/10.1182/blood-2008-01-135335
  27. Chong BH. ITP: Tregs come to the rescue. Blood 2010;116:4388-90. https://doi.org/10.1182/blood-2010-09-302364
  28. Alatrakchi N and Koziel M. Regulatory T cells and viral liver disease. J Viral Hepat 2009;16:223-9. https://doi.org/10.1111/j.1365-2893.2009.01081.x

Cited by

  1. Subpopulations of Regulatory T Cells in Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Behcet's Disease vol.27, pp.9, 2011, https://doi.org/10.3346/jkms.2012.27.9.1009
  2. Influence of tumors on protective anti-tumor immunity and the effects of irradiation vol.3, pp.None, 2011, https://doi.org/10.3389/fonc.2013.00014
  3. Decreased Levels of Circulating CD4+CD25+Foxp3+ Regulatory T Cells in Patients with Primary Antiphospholipid Syndrome vol.33, pp.4, 2011, https://doi.org/10.1007/s10875-012-9857-y
  4. CD4+CD25+High Foxp3+ Regulatory T Cells, B Lymphocytes, and T Lymphocytes in Patients With Acute ITP in Assiut Children Hospital vol.20, pp.1, 2011, https://doi.org/10.1177/1076029612454937
  5. Pacientes com lúpus eritematoso sistêmico e síndrome antifosfolípide secundária possuem números reduzidos de células B CD4+ CD25+ Foxp3+ (células vol.54, pp.3, 2011, https://doi.org/10.1016/j.rbr.2013.09.001
  6. Prognostic value of regulatory T cells in newly diagnosed chronic myeloid leukemia patients vol.19, pp.4, 2014, https://doi.org/10.1007/s10147-013-0615-9
  7. Extracts of Devil's Club (Oplopanax horridus) Exert Therapeutic Efficacy in Experimental Models of Acute Myeloid Leukemia vol.28, pp.9, 2011, https://doi.org/10.1002/ptr.5129
  8. FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4 + T regulatory cells vol.63, pp.11, 2011, https://doi.org/10.1007/s00262-014-1589-9
  9. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)‐35 in Murphy Roths Large (MRL)/lpr mice vol.181, pp.2, 2011, https://doi.org/10.1111/cei.12639
  10. Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia vol.21, pp.8, 2016, https://doi.org/10.1080/10245332.2015.1106814
  11. Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy vol.66, pp.11, 2017, https://doi.org/10.1007/s00262-017-2040-9
  12. CD4 + CD25 high CD127 low/- FoxP 3 + Regulatory T-Cell Population in Acute Leukemias: A Review of the Literature vol.2019, pp.None, 2011, https://doi.org/10.1155/2019/2816498